🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for HealthTech

Benchmark revenue and EBITDA valuation multiples for public comps like Johnson & Johnson, Danaher, Boston Scientific, UnitedHealth Group and Medtronic.

HealthTech

See analyst estimates and all valuation multiples for HealthTech
Company EV EV/LTM Revenue EV/LTM EBITDA
$617B 6.6x 17.3x
$307B 0.7x 11.6x
$286B 3.0x 16.9x
$221B 5.0x 19.8x
$199B 4.5x 16.7x
$166B 6.8x 21.7x
$164B 16.5x 38.6x
$152B 6.1x 21.2x
$150B 4.3x 14.9x
$121B 6.0x 19.2x
$51.5B 1.8x 9.1x
$43.1B 5.4x 13.7x
$28.8B 2.6x 13.1x
$28.1B 12.7x -84.9x
$25.8B 3.1x 9.4x
$25.6B 4.4x 15.1x
$24.8B 5.3x 18.3x
$22.1B 6.2x 20.5x
$21.5B 4.8x 14.7x
$17.2B 6.4x 26.6x
$13.0B 9.4x 50.8x
$11.0B 5.3x 14.5x
$10.6B 1.5x 8.1x
$6.2B 6.7x 27.4x
$6.1B 2.8x 11.0x
$6.0B 12.1x -237.7x
$5.6B 2.0x 8.6x
$5.4B 3.8x 11.4x
$5.1B 1.4x n/a
$5.1B 3.4x 13.9x
$5.0B 5.2x 17.5x
$5.0B 6.7x 79.4x
$4.9B 5.1x 8.2x
$4.9B 1.8x 4.4x
$4.8B 3.2x 8.8x
$4.6B 2.2x 10.9x
$4.3B 3.5x 12.5x
$4.2B 1.6x 7.2x
$4.2B 2.3x 10.6x
$3.7B 3.7x 17.6x
$3.7B 0.8x 7.9x
$3.5B 2.7x 8.5x
$3.1B 2.3x 11.7x
$2.8B 1.0x 6.5x
$2.7B 1.2x 6.7x
$2.6B 6.0x 64.5x
$2.4B 1.5x 5.9x
$2.3B 2.7x 54.6x
$2.2B 0.0x 1.8x
$2.1B 4.8x 23.6x
$2.0B n/a n/a
$1.9B 1.7x 12.5x
$1.7B 0.1x -9.2x
$1.7B 7.6x 60.7x
$1.5B 3.1x 15.1x
$1.4B 3.6x 12.0x
$1.3B n/a n/a
$1.2B 14.7x n/a
$1.2B 9.1x 46.2x
$1.2B 2.8x 8.9x
$1.2B 1.3x 4.7x
$935M 1.0x 2.8x
$869M 16.0x -18.4x
$846M 1.0x 2806.5x
$804M 3.5x 16.5x
$657M 4.5x 10.3x
$645M n/a n/a
$632M 7.1x 38.2x
$595M 6.7x -10.9x
$557M 2.1x 10.0x
$541M 2.7x 87.7x
$539M n/a n/a
$518M n/a n/a
$497M 1.9x -25.4x
$489M 0.6x 15.8x
$470M 0.3x 4.0x
$452M 2.0x 45.3x
$451M 2.8x 8.2x
$434M 369.8x -20.1x
$425M 6.7x 17.7x
$417M 12.9x n/a
$381M 1.2x 8.0x
$360M 12.8x 34.1x
$275M 1.4x 8.3x
$269M 1.9x 9.0x
$257M n/a n/a
$248M 208.4x -5.2x
$229M 2.7x 9.7x
$226M n/a n/a
$225M 0.2x 4.1x
$194M 0.4x 7.6x
$179M 2.6x 11.8x
$176M 2.1x 12.4x
$168M 4.4x 20.5x
$155M 0.8x 5.6x
$118M 0.5x 4.7x
$115M 2.0x -2.6x
$53.0M 1.6x 13.3x
$0.7M 0.0x -0.0x

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.